In a retrospective study by Wang et al., patients with moderate to severe cancer pain who were taking oxycodone exhibited elevated levels of IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ compared to the patients without cancer pain [59]. The gene discussed is IL2; the disease is cancer.